Tune in to our upcoming broadcast to learn more about advances in the treatment of tenosynovial giant cell tumor. Register today!

What Nurses Need to Know About GU Malignancies

LAURA S. WOOD, RN, MSN, OCN | August 23, 2019


At the 3rd annual School of Oncology Nursing, Oncology Nursing News® had the chance to sit down with Laura S. Wood, RN, MSN, OCN, renal cancer research coordinator at the Cleveland Clinic Taussig Cancer Center and one of the co-chairs of the School of Oncology Nursing, and discuss her presentation on GU malignancies highlighting one of the most important takeaways from the presentation.   

TRANSCRIPTION

So as far as a presentation on GU malignancies and supportive care, I think it's important for nurses to take home the awareness that bone metastasis is a challenge, it does occur, and we need to make sure we assess and intervene early in order to minimize the negative impact it has on a patient. If we can control their systemic disease, the challenge is bones and brain are oftentimes more sanctuary sights and may not have the same benefit from therapy. So, we need to be astute in our assessment and awareness of these potential sites for metastasis and make sure we're intervening early because there are definitely advances in the options to treat those problems.

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.